The local community of Naxos once again came together in great numbers to celebrate their hometown hero and the sport of windsurfing. As this is the season finale, the official European Champions were ...

STARBOARD ULTRA 86L: 2025 TEST REVIEW THE VERDICT Providing some comfort when powered, the Ultra looks for a proactive rider who can provide and drive (…) ...

Activist investor Starboard Value has sharpened its criticism of Pfizer Inc. (NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on its promises of ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. Starboard has called on Pfizer’s board to “hold management ...

Starboard Value just shook things up, taking a bold stake in Kenvue (NYSE:KVUE), the company behind everyday staples like Band-Aid, Listerine, and Tylenol. Since breaking away from Johnson ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has Johnson & Johnson’s consumer health spinout Kenvue in its sights.

He also shared a version of the presentation his hedge fund Starboard presented to Pfizer officials at a meeting last week. "It's not often that investors and shareholders are able to see what we ...

Activist investor Starboard Value could push for Kenvue (NYSE:KVUE) to divest some/all of its "challenged" skin, healthcare and beauty division after a report that the investor has accumulated a ...

Gabby Jones / Bloomberg via Getty Images Shares of Kenvue (KVUE) took off Monday morning on indications activist investor Starboard Value has taken a large stake in the consumer health products maker.

NEW YORK (Reuters) -Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's board needs to hold management accountable for its underperformance, ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Speculation surrounds the reversal, with Jeff Smith, CEO of Starboard, claiming Pfizer pressured the ex-executives with potential legal consequences and bonus clawbacks. Despite not playing an ...